Similar articles

• The distribution of Cr51 labeled E. coli endotoxin in the generalized Shwartzman reaction.

  SMITH RT, BRAUDE AI, CAREY FJ. SMITH RT, et al. J Clin Invest. 1957 May;36(5):695-9. doi: 10.1172/JCI103471. J Clin Invest. 1957. PMID: 13428859 Free PMC article. No abstract available.
• Studies with radioactive endotoxin. III. The effect of tolerance on the distribution of radioactivity after intravenous injection of Escherichia coli endotoxin labeled with Cr51.

  CAREY FJ, BRAUDE AI, ZALESKY M. CAREY FJ, et al. J Clin Invest. 1958 Mar;37(3):441-57. doi: 10.1172/JCI103624. J Clin Invest. 1958. PMID: 13513775 Free PMC article. No abstract available.
• Effects of human apolipoprotein A-I on endotoxin-induced leukocyte adhesion on endothelial cells in vivo and on the growth of Escherichia coli in vitro.

  Thaveeratitham P, Plengpanich W, Naen-Udorn W, Patumraj S, Khovidhunkit W. Thaveeratitham P, et al. J Endotoxin Res. 2007;13(1):58-64. doi: 10.1177/0968051907078611. J Endotoxin Res. 2007. PMID: 17621547
• Efficacy of an Escherichia coli J-5 mutant strain bacterin in the protection of calves from endotoxin disease caused by subcutaneous challenge with endotoxins from Escherichia coli.

  Deluyker HA, Rossitto P, Van Oye SN, Cullor JS. Deluyker HA, et al. Vaccine. 2004 Dec 16;23(5):709-17. doi: 10.1016/j.vaccine.2004.05.021. Vaccine. 2004. PMID: 15542194 Clinical Trial.
• Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.

  Buijs J, Dofferhoff AS, Mouton JW, van der Meer JW. Buijs J, et al. J Antimicrob Chemother. 2007 May;59(5):926-33. doi: 10.1093/jac/dkm073. Epub 2007 Mar 29. J Antimicrob Chemother. 2007. PMID: 17395686